Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative
- 1 February 2009
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 5 (2) , 92-98
Abstract
Ature Clinical Practice Oncology will deliver timely interpretations of key research developments, translating the latest findings into clinical practice. Our Editor-in-Chief and international Advisory Board will ensure comprehensive coverage of topical issues throughout the year, with the highest standards of editorial quality and integrity that are hallmarks of Nature Publishing Group.Keywords
This publication has 60 references indexed in Scilit:
- Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type IPain, 2008
- Non‐Steroidal Anti‐Inflammatory Drugs, Cyclooxygenase‐2 and the Bone Healing ProcessBasic & Clinical Pharmacology & Toxicology, 2007
- Nerve Growth Factor Expression after Plantar Incision in the RatAnesthesiology, 2007
- Acute Post-Surgical Pain Management: A Critical Appraisal of Current PracticeRegional Anesthesia & Pain Medicine, 2006
- Pain management today—what have we learned?Clinical Rheumatology, 2006
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cyclo-Oxygenase-2 InhibitorsSports Medicine, 2005
- COX inhibitors and their effects on bone healingExpert Opinion on Drug Safety, 2004
- Existence of brain-derived neurotrophic factor and vanilloid receptor subtype 1 immunoreactive sensory DRG neurons innervating L5/6 intervertebral discs in ratsJournal of Orthopaedic Science, 2003